Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting
Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;
Reumatol Clin. 2022;18:567-73
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Javier Narváez; Petra Díaz del Campo Fontecha; Noé Brito García; Gema Bonilla; Myriam Aburto; Iván Castellví; Esteban Cano-Jiménez; Natalia Mena-Vázquez; M. Asunción Nieto; Ana María Ortiz; Claudia Valenzuela; Miguel Ángel Abad Hernández; Isabel Castrejón; María Correyero Plaza; Félix Manuel Francisco Hernández; María Vanesa Hernández Hernández; José Antonio Rodríquez Portal;